Tidal Medical Technologies
InSee Boosts Patient Engagement and Outcomes

Hospital acquired pneumonia (HAP) is one of the leading causes of hospital readmission and mortality. Annually, HAP leads to over 140,000 readmissions costing the US hospitals over $10 billion. Currently, the front-line pneumonia prevention protocol is Incentive Spirometry. Research has shown that patients are rarely compliant with their incentive spirometry therapy and that adding smart patient reminders and monitoring functionalities can significantly improve patient compliance and outcomes. The team at Tidal Medical developed a Smart Incentive Spirometry System to do just that.

“The current Incentive spirometry does not offer an engaging therapy option and with no way to quantifiably monitor patient compliance, it’s difficult to identify patients at the highest risk for pneumonia,” says Mehdi Arani, co-founder and CEO of Tidal Medical Technologies.

InSee attaches to existing Incentive Spirometers and converts them into a smart system to quantitatively tracks patient engagement, encouraging more consistent usage to help reduces respiratory complications such as pneumonia and the risk of hospital readmission.

InSee, Smart Incentive Spirometry System offers three distinct features to help reduce respiratory complications:

1. Audible & visual patient reminders and coaching to increase patient compliance and treatment efficacy.

2. Continuous monitoring of patient compliance and max tidal volume to help clinician identify the patients at the highest risk.

3. Predictive analytics – a future feature that harnesses the continuous data collection to help identify patients at highest risk much earlier, enabling early intervention.

InSee can also transmit data to the cloud, making it accessible for medical professionals to analyze and monitor patient progress.

This allows for early detection of noncompliance and low tidal max volume, triggering prompt intervention to help respiratory therapist identify and help the patients most at risk. The system utilizes its real-time monitoring capability and patient reminder functions to provide a comprehensive solution for patient engagement and treatment compliance.

InSee’s versatile and scalable design makes it suitable for various healthcare settings, from large acute hospitals to outpatient, Long-term care (skilled nursing) and even for home use. It is beneficial for post-surgical patients, individuals with respiratory complications such as COPD.

Leveraging the power of artificial intelligence and the continuous respiratory data collection, we hope to identify patients who are most likely to get pneumonia after discharge, hence intervene early to minimize readmission and mortality risks.

In the future, Tidal Medical Technologies aims to use volume fluctuations as predictors for respiratory issues and pneumonia. Through continuous monitoring and analysis, the company hopes to gain deeper insights into these health issues and ultimately develop more effective treatment solutions.

InSee’s introduction marks a significant advancement in the respiratory care sector. By addressing the challenges surrounding incentive spirometer usage and compliance, Tidal Medical Technologies improves patient outcomes, reduces complications, and enhances the overall quality of respiratory care. Due to its commitment to innovation and using cutting-edge technology, Tidal Medical is poised to make a substantial impact in the healthcare industry, improving the lives of countless patients worldwide.

To learn more, visit www.tidalmed.tech